Q BioMed (QBIO) News Today → Top Project Outperforms BTC in 2023… (From Crypto 101 Media) (Ad) Free QBIO Stock Alerts $0.0003 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineClearside Biomedical Q4 2023 Earnings Previewmsn.com - March 11 at 7:34 PMQ BioMed Stock (OTC:QBIO) Dividends: History, Yield and Datesbenzinga.com - February 24 at 3:23 AMBiogen Inc. (BIIB) Lags Q4 Earnings and Revenue Estimatesmsn.com - February 13 at 1:26 PMBioxyne’s Q2 FY24 revenue surpasses $2.5m on Aussie medicinal cannabis growthmsn.com - January 28 at 11:09 PMQ BioMed Inc QBIOmorningstar.com - November 16 at 1:23 PMQBIO Q BioMed Inc.seekingalpha.com - August 18 at 4:51 AMQ BioMed receives US patent and notice of allowance in Europe for Uttroside B; seeks ways to boost shareholder valueproactiveinvestors.com - April 14 at 10:53 AMQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europefinance.yahoo.com - April 14 at 10:53 AMQ BioMed Stock (OTC:QBIO), Quotes and News Summarybenzinga.com - March 3 at 4:23 PMQ BioMed gets notice of allowable US patent for liver cancer treatment Uttroside Bproactiveinvestors.com - February 10 at 3:27 PMQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Officefinance.yahoo.com - February 10 at 8:27 AMShort Volatility Alert: Q Biomed Incbenzinga.com - January 12 at 2:36 PMQ BioMed Inc. (QBIO)finance.yahoo.com - January 1 at 5:15 PMQ BioMed boosted by multi-million dollar asset as it converts long-term royalty into equity stake in Mannin Researchproactiveinvestors.com - November 14 at 2:22 PMQ BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC.finance.yahoo.com - November 14 at 9:20 AMQ BIOMED PROVIDES SHAREHOLDER UPDATEprnewswire.com - October 11 at 8:38 AMQ Biomed announces patent for groundbreaking GDF15 biomarker for glaucoma detection and treatmentproactiveinvestors.com - September 27 at 1:02 PMQ BIOMED ANNOUNCES ISSUANCE OF PATENT FOR GROUNDBREAKING GDF15 BIOMARKERfinance.yahoo.com - September 27 at 1:02 PMTraders News Source Senior Editor Mark Roberts Interviews Denis D Corin, CEO and Chairman Q BioMed Inc.finance.yahoo.com - August 25 at 10:16 AMQ BioMed Inc. Provides Update to Shareholdersfinance.yahoo.com - July 29 at 11:39 AMQ BioMed welcomes study that highlights the safety and efficacy of Uttroside-B chemotherapeuticproactiveinvestors.com - July 26 at 5:43 PMQ BioMed announces publication of pre-clinical research showing superior safety and efficacy against current first line therapy of its drug candidate Uttroside-B for liver cancerfinance.yahoo.com - July 26 at 12:43 PMQ BioMed Inc (QBIO)investing.com - May 11 at 11:28 PMQ BioMed says its strategy is paying off as it outlines its value proposition in multibillion-dollar marketsproactiveinvestors.com - May 6 at 12:51 PMQ BioMed Outlines Strategy and Value Proposition in Multi-Billion Dollar Marketsfinance.yahoo.com - May 6 at 12:51 PMQ BioMed announces publication of research supporting efficacy and development of its Uttroside-B chemotherapeutic to treat liver cancerproactiveinvestors.com - March 16 at 12:00 PMQ BioMed announces publication of research showing augmented efficacy of its drug candidate Uttroside-B against liver cancerfinance.yahoo.com - March 16 at 12:00 PMQ BioMed expands Strontium89 to Chinese market with $500K orderseekingalpha.com - March 7 at 2:34 PMQ BioMed Announces Initial $500k Order of Strontium89 to Chinese Marketfinance.yahoo.com - March 7 at 9:33 AMQ BioMed outlines strategic direction and goals for 2022proactiveinvestors.com - February 14 at 7:16 PMQ BioMed Outlines Strategic Direction for 2022finance.yahoo.com - February 14 at 7:16 PMQ BioMed says it is seeing a ‘significant uptrend’ in revenues as it continues to roll out Strontium89proactiveinvestors.com - December 16 at 10:17 PMNA Proactive news snapshot: Q BioMed Inc, FansUnite Entertainment Inc, BioSig Technologies Inc, Endexx Corporation, Doré Copper ...proactiveinvestors.com - December 16 at 5:17 PMQ BioMed Shows Significant Uptrend in Revenues in Year-End Updatefinance.yahoo.com - December 16 at 12:17 PMQ BioMed to forms partnership with EVERSANA to help commercialize Strontium89proactiveinvestors.com - November 8 at 6:01 PMQ BioMed Bolsters Commercialization of Strontium89 with EVERSANA Partnershipfinance.yahoo.com - November 8 at 1:01 PMQ BioMed raises $2M with plans for uplisting on NASDAQ; updates on activity for coming monthsproactiveinvestors.com - October 26 at 12:37 AMQ BioMed Inc. Provides Shareholder Updatefinance.yahoo.com - October 25 at 9:34 AMQ BioMed sees uptick in 4Q sales of Strontium89 amid commercial rolloutproactiveinvestors.com - September 28 at 10:08 AMQ BioMed Inc. Provides Update on Strontium89 Commercial Roll Out Revenue Up in 4th Quarter with Positive Trendfinance.yahoo.com - September 28 at 10:08 AMFinancialNewsMedia.com: Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variantsfinanznachrichten.de - September 22 at 1:11 PMQ BioMed Inc. Updates on COVID-19 Therapeutic Development and Clinical Trials - MAN-19 therapeutic program heading to clinical trial in early 2022finance.yahoo.com - September 22 at 1:11 PMQ BioMed expects to receive South Korean patent for its liver cancer chemotherapy candidateproactiveinvestors.com - August 25 at 5:24 PMQ BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent in South Korea and Shows Promising Results in Initial Pre-Clinical Testingfinance.yahoo.com - August 24 at 8:29 AMQ BioMed strikes distribution agreement for Strontium89 sales in Canadaproactiveinvestors.com - August 10 at 3:07 PMQ BioMed Signs Distribution Agreement with isoSolutions for the Sales of Strontium89 in Canadafinance.yahoo.com - August 10 at 9:59 AM Get Q BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem. Protect your retirement savings from the inevitable devaluation of the dollar… QBIO Media Mentions By Week QBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QBIO News Sentiment▼0.000.61▲Average Medical News Sentiment QBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QBIO Articles This Week▼00▲QBIO Articles Average Week Get Q BioMed News Delivered to You Automatically Sign up to receive the latest news and ratings for QBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NOVN News WCUI News PPCB News PRED News ACUR News HDVY News HGEN News STAB News BOMH News BRSH News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:QBIO) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI healthcare stock poised for 36,996% growth?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Q BioMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.